PAR-25-328 - Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
On This Page: 2
Active NOSIs
| Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
|---|
Expired NOSIs
| Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
|---|---|---|---|---|---|
| Notice of Special Interest (NOSI): Discovery and Development of Natural Products to Treat Substance Use Disorders (SUDs) | NOT-DA-25-032 | NIDA NCCIH | Nov 25, 2024 | Sep 9, 2025 | R01, UG3/UH3, U01, R21 |
| Notice of Special Interest (NOSI): HEAL Initiative: Grand Opportunity in Medications Development for Substance-Use Disorders | NOT-DA-23-009 | NIDA | Sep 29, 2022 | Sep 2, 2025 | U01 |

